Modified Carbapenem Inactivation Method for Phenotypic Detection of Carbapenemase Production among Enterobacteriaceae
Open accessThe DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
The ability of clinical microbiology laboratories to reliably detect carbapenemase-producing carbapenem-resistant Enterobacteriaceae (CP-CRE) is an important element of the effort to prevent and contain the spread of these pathogens and an integral part of antimicrobial stewardship. All existing methods have limitations. A new, straightforward, inexpensive, and specific phenotypic method for the detection of carbapenemase production, the carbapenem inactivation method (CIM), was recently described. Here we describe a two-stage evaluation of a modified carbapenem inactivation method (mCIM), in which tryptic soy broth was substituted for water during the inactivation step and the length of this incubation was extended. A validation study was performed in a single clinical laboratory to determine the accuracy of the mCIM, followed by a nine-laboratory study to verify the reproducibility of these results and define the zone size cutoff that best discriminated between CP-CRE and members of the family Enterobacteriaceae that do not produce carbapenemases. Bacterial isolates previously characterized through whole-genome sequencing or targeted PCR as to the presence or absence of carbapenemase genes were tested for carbapenemase production using the mCIM; isolates with Ambler class A, B, and D carbapenemases, non-CP-CRE isolates, and carbapenem-susceptible isolates were included. The sensitivity of the mCIM observed in the validation study was 99% (95% confidence interval [95% CI], 93% to 100%), and the specificity was 100% (95% CI, 82% to 100%). In the second stage of the study, the range of sensitivities observed across nine laboratories was 93% to 100%, with a mean of 97%; the range of specificities was 97% to 100%, with a mean of 99%. The mCIM was easy to perform and interpret for Enterobacteriaceae , with results in less than 24 h and excellent reproducibility across laboratories.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically
Ferraro, M. J. (2000) · Cited by 16,875
Self-citationAntibiotic resistance threats in the United States, 2019
(U.S.), C. F. D. C. A. P. (2019) · doi:10.15620/cdc:82532 · Cited by 5,782
Identification of acquired antimicrobial resistance genes
Zankari, E., Hasman, H., Cosentino, S., Vestergaard, M., Rasmussen, S., Lund, O., Aarestrup, F. M., & Larsen, M. V. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks261 · Cited by 4,980 · cited 1×
“com/chrisgulvik/c-SSTAR), and a command line version of SSTAR (35) was used with a compatible ResFinder database (36) (accessed 25 October 2016).”
MethodGlobal Spread of Carbapenemase-producing Enterobacteriaceae
Nordmann, P., Naas, T., & Poirel, L. (2011) · Emerging Infectious Diseases · doi:10.3201/eid1710.110655 · Cited by 2,378
Hospital-Acquired Infections Due to Gram-Negative Bacteria
Peleg, A. Y., & Hooper, D. C. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0904124 · Cited by 1,495
OXA-48-like carbapenemases: the phantom menace
Poirel, L., Potron, A., & Nordmann, P. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks121 · Cited by 924
Boucher, H. W., Talbot, G. H., Benjamin, D. K., Bradley, J., Guidos, R. J., Jones, R. N., Murray, B. E., Bonomo, R. A., Gilbert, D., & for the Infectious Diseases Society of America (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit152 · Cited by 700
Vital signs: carbapenem-resistant Enterobacteriaceae.
(2013) · PubMed Central · Cited by 603
van der Zwaluw, K., de Haan, A., Pluister, G. N., Bootsma, H. J., de Neeling, A. J., & Schouls, L. M. (2015) · PLOS ONE · doi:10.1371/journal.pone.0123690 · Cited by 486
Tamma, P. D., Goodman, K. E., Harris, A. D., Tekle, T., Roberts, A., Taiwo, A., & Simner, P. J. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/ciw741 · Cited by 402
Self-citationLaboratory Detection of Enterobacteriaceae That Produce Carbapenemases
Doyle, D., Peirano, G., Lascols, C., Lloyd, T., Church, D. L., & Pitout, J. D. D. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.02117-12 · Cited by 363
Evaluation of Methods To Identify the Klebsiella pneumoniae Carbapenemase in Enterobacteriaceae
Anderson, K. F., Lonsway, D. R., Rasheed, J. K., Biddle, J., Jensen, B., McDougal, L. K., Carey, R. B., Thompson, A., Stocker, S., Limbago, B., et al. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.00015-07 · Cited by 355
Self-citationThe Problem of Carbapenemase-Producing-Carbapenem-Resistant-Enterobacteriaceae Detection
Lutgring, J. D., & Limbago, B. M. (2016) · Journal of Clinical Microbiology · doi:10.1128/jcm.02771-15 · Cited by 272
Self-citationFirst Report of Ceftazidime-Avibactam Resistance in a KPC-3-Expressing Klebsiella pneumoniae Isolate
Humphries, R. M., Yang, S., Hemarajata, P., Ward, K. W., Hindler, J. A., Miller, S. A., & Gregson, A. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01165-15 · Cited by 255
Emerging Issues in Gram-Negative Bacterial Resistance
Vasoo, S., Barreto, J. N., & Tosh, P. K. (2015) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2014.12.002 · Cited by 182
SSTAR, a Stand-Alone Easy-To-Use Antimicrobial Resistance Gene Predictor
de Man, T. J. B., & Limbago, B. M. (2016) · mSphere · doi:10.1128/msphere.00050-15 · Cited by 84
Self-citationPollett, S., Miller, S. A., Hindler, J. A., Uslan, D. Z., Carvalho, M., & Humphries, R. M. (2014) · Journal of Clinical Microbiology · doi:10.1128/jcm.01397-14 · Cited by 79
Chea, N., Bulens, S. N., Kongphet-Tran, T., Lynfield, R., Shaw, K. M., Vagnone, P. S., Kainer, M. A., Muleta, D. B., Wilson, L. E., Vaeth, E., et al. (2015) · Emerging infectious diseases · doi:10.3201/eid2109.150198 · Cited by 67
Self-citationYang, S., Hemarajata, P., Hindler, J. A., Li, F., Adisetiyo, H., Aldrovandi, G. M., Sebra, R., Kasarskis, A., MacCannell, D., Didelot, X., et al. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/ciw876 · Cited by 47
Tamma, P. D., Huang, Y., Opene, B. N. A., et al. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00838-16 · Cited by 37
Hemarajata, P., Yang, S., Hindler, J. A., & Humphries, R. M. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00425-15 · Cited by 31
Yang, S., Hemarajata, P., Hindler, J. A., Ward, K. W., Adisetiyo, H., Li, F., Aldrovandi, G. M., Green, N. M., Russell, D., Rubin, Z., et al. (2015) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2015.12.019 · Cited by 14
Cited by
NDM Metallo-β-Lactamases and Their Bacterial Producers in Health Care Settings
Wu, W., Feng, Y., Tang, G., Qiao, F., McNally, A., & Zong, Z. (2019) · Clinical Microbiology Reviews · doi:10.1128/cmr.00115-18 · Cited by 700
Carbapenemase-Producing Organisms: A Global Scourge
Bonomo, R. A., Burd, E. M., Conly, J., Limbago, B. M., Poirel, L., Segre, J. A., & Westblade, L. F. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/cix893 · Cited by 656
Self-citationThe Global Ascendency of OXA-48-Type Carbapenemases
Pitout, J. D. D., Peirano, G., Kock, M. M., Strydom, K.-A., & Matsumura, Y. (2019) · Clinical Microbiology Reviews · doi:10.1128/cmr.00102-19 · Cited by 478
Phenotypic Detection of Carbapenemase-Producing Organisms from Clinical Isolates
Tamma, P. D., & Simner, P. J. (2018) · Journal of Clinical Microbiology · doi:10.1128/jcm.01140-18 · Cited by 293
Self-citationBahr, G., González, L. J., & Vila, A. J. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00138 · Cited by 266
Metadata
- Authors
- Pierce, V. M., Simner, P. J., Lonsway, D. R., Roe-Carpenter, D. E., Johnson, J. K., Brasso, W. B., Bobenchik, A. M., Lockett, Z. C., Charnot-Katsikas, A., Ferraro, M. J., Thomson, R. B., Jenkins, S. G., Limbago, B. M., & Das, S.
- Venue
- Journal of Clinical Microbiology
- Publisher
- American Society for Microbiology
- Published
- 2017-08
- Volume
- 55
- Issue
- 8
- Pages
- 2321-2333
- ISSN
- 0095-1137 (ISSN-L)
- 1098-660X
- OpenAlex
- W2604239844
- Cited by
- 405
- References
- 22
- FWCI
- 12.30
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.